Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

NEWS

Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
4548 Views
Comment
Sign in to post a comment